Issue #10: Integrated cytotoxicity screening and in silico analysis of coumarin nucleoside conjugates as computationally modeled VEGFR-2 inhibitors: oncocyte cytotoxicity, molecular docking, and dynamics simulation studies.

Signal of the Day

Integrated cytotoxicity screening and in silico analysis of coumarin nucleoside conjugates as computationally modeled VEGFR-2 inhibitors: oncocyte cytotoxicity, molecular docking, and dynamics simulation studies.

The development of small-molecule tyrosine kinase inhibitors remains a high-priority strategy in modern oncology, particularly those targeting the Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) to disrupt pathological angiogenesis. This study utilized a dual-methodology approach to evaluate a novel series of five coumarin nucleoside conjugates ( 5a - 5e ) as potential anti-cancer agents. Initially, the compounds’ drug-likeness was confirmed via ADMET prediction, which established favorable pharmacokinetic profiles. This was followed by an integrated MTT cytotoxicity screening against Oct1 (head and neck) and C33a (cervical) cancer cell lines, which identified compound 5d as the most potent cellular agent. The core of the investigation involved a comprehensive in silico analysis targeting the VEGFR-2 tyrosine kinase domain (TKD). Molecular docking revealed that all five compounds possess significantly superior predicted binding affinities compared to the native ligand, ATP (- 25.44 kJ/mol). Critically, the primary cellular lead 5d (- 29.46 kJ/mol) and the strongest binder 5e (- 31.30 kJ/mol) both surpassed the affinity of the clinical benchmark, Sorafenib (- 28.80 kJ/mol), confirming their high potential as competitive inhibitors. Further validation using Molecular Dynamics (MD) simulation and MMPBSA analysis demonstrated exceptional dynamic stability and thermodynamic preference for the TKD-ligand complexes, firmly supporting the predicted binding hypothesis. In conclusion, compounds 5d and 5e are validated lead candidates possessing favorable absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties, direct cellular cytotoxicity, and a robust computationally modeled dual-action profile. Future research is urgently mandated to perform VEGFR-2-specific functional assays to definitively validate the predicted anti-angiogenic mechanism and conduct in-vivo studies to assess therapeutic efficacy.

Why this matters: Essential ground-truth data for validating next-gen foundation models like Boltz or Chai.

Also Worth Reading

AlphaFold for Docking Screens.

AlphaFold is an AI system developed by Google DeepMind to generate three-dimensional structures of proteins without experimental data. The models created with AlphaFold are available on the AlphaFold Protein Structure Database (AlphaFoldDB) ( https://alphafold.ebi.ac.uk/ ). The AlphaFold database is searchable by sequence and protein identification. This chapter focuses on an AlphaFold model and its use for docking screens using Molegro Virtual Docker. We rely on Jupyter Notebooks to integrate docking simulations and build regression models based on the atomic coordinates of protein-pose complexes. Our study focuses on constructing a neural network regression model to predict the inhibition of cyclin-dependent kinase 19 (CDK19). This enzyme is a target for anticancer drugs and does not have experimental data for its atomic coordinates. We utilize the Molegro Data Modeller to construct a regression model based on docking results of inhibitors for which binding affinity data is available. All CDK19 datasets and Jupyter Notebooks discussed in this work are available at GitHub: https://github.com/azevedolab/docking#readme .

Modeling Protein-Protein Complexes by Combining pyDock and AlphaFold.

The lack of experimental structures for the majority of protein-protein complexes has motivated the development of a variety of strategies for the structural modeling of protein complexes, such as computational docking, in active development for the last decades, and the more recent artificial intelligence (AI)-based ground-breaking methodologies. Among the existing computational docking methods, Python docking (pyDock) has shown competitive predictive rates and high robustness over the years. However, the field has dramatically changed with the appearance of artificial intelligence (AI)-based methods, like AlphaFold. While structure prediction of individual proteins is virtually solved by this program, the focus is now on how to improve the prediction of challenging cases like antibody-antigen complexes, multiprotein complexes, weak interactions, or highly flexible interacting proteins. Successful strategies are based on the generation of more diverse sets of models and the integration with other “classical” approaches that facilitate the identification of the correct models. Here, we will show in practical terms how to combine the structural modeling capabilities of AlphaFold with the energy-based scoring function in pyDock to improve structural predictions in challenging protein-protein complexes.

Combining network pharmacology, machine learning, molecular docking, molecular simulation dynamics and experimental validation to explore the mechanism of Zhenwu decoction in treating major depression through TNF-α pathways.

Background Major depressive disorder (MDD) is a severe psychophysiological condition characterized by cognitive decline, low energy, weight loss, insomnia, and increased suicide risk, posing a significant burden on global health. Zhenwu decoction (ZWD), a traditional Chinese medicine, has shown therapeutic potential in alleviating MDD symptoms. However, its complex composition has limited the understanding of its underlying pharmacological mechanisms. This study aimed to explore the antidepressant mechanisms of ZWD in the treatment of MDD. Methods Active compounds and potential targets of ZWD were identified through database screening and network pharmacology analysis. These targets were intersected with MDD-related genes to construct a protein-protein interaction network. Core targets were further refined using random forest algorithms. Molecular docking and molecular dynamics simulations were employed to evaluate the binding affinity and stability between key compounds and core targets. Experimental validation was conducted in a lipopolysaccharide (LPS)-induced mouse model of depression using behavioral testing, measurement of inflammatory cytokines, and gene expression analysis. Results Network pharmacology and machine learning identified TNF-α signaling as key pathways in the antidepressant effects of ZWD. Enrichment analysis highlighted the involvement of Lipid and atherosclerosis, the IL-17 signaling pathway. Core targets, including PPARG, F10, AR, TNF, PIK3CG, ADH1C, and GABRA6, were predicted to mediate its effects. Molecular docking and dynamics simulations confirmed strong binding of ZWD components, especially kaempferol, to TNF-α, inhibiting its expression. In vivo, ZWD improved anxiety/depressive-like behaviors in LPS-treated mice, evidenced by better performance in the behavioral tests. ZWD also reduced neuroinflammation, with decreased Tnf-α levels, and reduced IBA-1 and GFAP staining, indicating reduced microglial and astrocyte activation. These results suggest that ZWD alleviates depression through modulation of TNF-α-mediated inflammation. Conclusions These findings suggest that ZWD exerts antidepressant effects primarily by modulating TNF-α-mediated inflammatory pathways, providing a comprehensive molecular and experimental framework supporting its clinical potential in MDD treatment.

Research & AI Updates

• Tim Hunt warns AI can’t replace curiosity in Korea’s quest for Nobel-level science - CHOSUNBIZ - Chosunbiz — Tim Hunt warns AI can’t replace curiosity in Korea’s quest for Nobel-level science - CHOSUNBIZ    Chosunbiz.
• Decoding Life’s Blueprint: How AlphaFold 3 is Redefining the Frontier of Medicine - FinancialContent — Decoding Life’s Blueprint: How AlphaFold 3 is Redefining the Frontier of Medicine    FinancialContent.
• 200 million views in 4 weeks: Google AI CEO Demis Hassabis celebrates success of The Thinking Game docume - Times of India — 200 million views in 4 weeks: Google AI CEO Demis Hassabis celebrates success of The Thinking Game docume    Times of India.

From the Industry

• Retro Bio commences first-in-human trial - Longevity.Technology — Retro Bio commences first-in-human trial    Longevity.Technology.
• Oncodesign Precision Medicine and Navigo Proteins Announce the End of Their Collaboration in the Development of Radiotheranostics - Business Wire — Oncodesign Precision Medicine and Navigo Proteins Announce the End of Their Collaboration in the Development of Radiotheranostics    Business Wire.

Quick Reads

Unraveling the mechanism of curcumin in coronary slow flow phenomenon through network pharmacology and molecular docking.

The coronary slow flow phenomenon (CSFP) is associated with an increased risk of adverse cardiovascular events, yet standardized treatment is lacking. Read more →

Assessing the validity of leucine zipper constructs predicted by AlphaFold.

AP-1 transcription factors are a network of cellular regulators that combine in different dimer pairs to control a range of pathways involved in differentiation, growth, and cell death. Read more →

A screening strategy for bioactive components from Amaranth: An integrated approach of network pharmacology, molecular docking and molecular dynamics simulation.

Amaranth is a traditional medicinal and forage plant with promising anti-inflammatory properties. Read more →

Molecular docking and molecular dynamics study of PUFAs from <i>Navicula salinicola</i>: prospective antiviral strategies targeting the SARS-CoV-2 spike protein.

The emergence of novel viral infections, such as SARS-CoV-2, H5N2, and H7N9, among recently identified viruses, has highlighted the urgent need for new antiviral therapeutics. Read more →

Genome-wide analysis, expression profiling and molecular docking of tomato (Solanum lycopersicum) calmodulin (SlCaM) proteins in cadmium stress adaptation.

Calcium ions (Ca 2+ ) are essential for plant development and stress responses, including heavy metal (HM) stress. Read more →

The Mechanism of <i>Andrographis paniculata</i> in the Treatment of Influenza Explored via Network Pharmacology and Molecular Docking.

Objective The objective of this study is to investigate the potential mechanisms of Andrographis paniculata in treating influenza using network pharmacology and molecular docking approaches. Read more →

Investigating the therapeutic potential of pinocembrin in Alzheimer’s disease: insights from network pharmacology and molecular docking.

The complicated neurodegenerative disease known as Alzheimer’s disease (AD) is typified by neural malfunction, cognitive impairment, and gradual memory loss. Read more →

Oxindole based sulfonyl derivatives synthesized as potent inhibitors of alpha amylase and alpha glucosidase along with their molecular docking study.

Diabetes mellitus, a persistent metabolic disorder, impedes the proper metabolism of proteins, carbohydrates, and lipids, leading to various physiological complications. Read more →

Pipeline Tip

Use Snakemake for reproducible end-to-end protein design workflows.

Resources & Tools

• Dataset: AlphaFold Structure Database - 200M+ predicted structures from DeepMind/EMBL-EBI.
• Dataset: Uniprot Knowledgebase - The world’s most comprehensive resource for protein sequence and annotation.
• Tool: ReFOLD4 - Sophisticated protein structure refinement tool for improving model quality. View all tools →
• Tool: FunFOLD5 - Automated system for protein ligand-binding site prediction and function annotation. View all tools →
• Event: Structural Biology Events (Open)
• Event: Protein Design Hub (LinkedIn Group) (Ongoing)
• Job: Mercor hiring Computational Bioinformatics Analyst in India - LinkedIn India at Bioinformatics Careers
• Job: Inside Higher Ed hiring Assistant or Associate Professor in Biostatistics and Bioinformatics in Lexington, KY - LinkedIn at Bioinformatics Careers

Deep learning is not a magic wand, but a powerful lens for structural biology. — Recep Adiyaman